The Effects of Telerehabilitation in Patients With COPD

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-04-01

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Chronic Obstructive Pulmonary Disease is a serious public health problem worldwide and it is a leading cause of mortality and morbidity. Nowadays, COPD patients are increasing in all societies and the problems that arise during the life of these patients increase the need for care and rehabilitation. Pulmonary rehabilitation has proven to be the best supportive treatment for individuals with COPD. However, there are difficulties in rehabilitation practices in terms of the fragility of patients, transportation and access problems. Telerehabilitation allows patients who cannot access rehabilitation due to their geographical, economic or physical disabilities to benefit from rehabilitation services. There are different studies demonstrating the effect of telerehabilitation in COPD patients and confirming that it is safe, but it is a developing area and has a limited area of use.

In this randomized controlled study, it is aimed to examine the effect of telerehabilitation training on respiratory functions, exercise capacity, quality of life, fatigue and psychosocial factors in individuals with COPD via video conferencing including respiratory exercises and postural exercises.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Telerehabilitation Approaches in Chronic Obstructive Pulmonary Patients

NCT04694729

Telerehabilitation COPD

UNKNOWN NA

Telerehabilitation in COPD

NCT05053061

COPD

RECRUITING NA

The Effectiveness Pulmonary Telerehabilitation and Cognitive Telerehabilitation in COPD Patients

NCT05222295

Severe Chronic Obstructive Pulmonary Disease Dyspnea Muscle Weakness +9 more

COMPLETED NA

The Effect of Home-Based Monitoring, Exercise Training

NCT06128902

COPD Patients

COMPLETED NA

Telerehabilitation in Patients With Fibrosing Interstitial Lung Diseases

NCT05166057

Fibrosing Interstitial Lung Disease Telerehabilitation

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COPD

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Treatment Group

Group Type EXPERIMENTAL

Treatment

Intervention Type OTHER

Telerehabilitation including pulmonary rehabilitation and posture exercises at 8 weeks in total with 2 sessions per week

Control Group

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Treatment

Telerehabilitation including pulmonary rehabilitation and posture exercises at 8 weeks in total with 2 sessions per week

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

telerehabilitation

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Having been diagnosed with chronic obstructive pulmonary disease according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria
* Not having an attack in the last 2 months
* Volunteering to participate in the study
* Being between the ages of 40-80
* To have a device that can be used in telerehabilitation application and an active internet connection.

Exclusion Criteria

* Unstable angina, previous myocardial infarction, severe congestive heart failure resistant to medical therapy, uncontrolled hypertension, cancer, neurological or musculoskeletal disorders with functional limitations
* Currently addicted to alcohol or drugs
* Having an injury to the lower extremity such as sprains, sprains or fractures in the last 6 months, not being able to perform independent ambulation
* Having serious vision and hearing problems
* Having severe cognitive impairment

Minimum Eligible Age

40 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No